根据年龄组对西班牙基线补丁测试系列的补丁测试结果:从2019年到2023年的多中心前性研究
David Pesqué1,2, Nidia Planella-Fontanillas1,2, Leopoldo Borrego3
1Servicio de Dermatología, Hospital del Mar Research Institute, Barcelona, Spain.
Contact dermatitis
|October 12, 2024
概括
贴片检测结果表明皮肤敏感性因年龄而异,中年成人呈现的阳性率最高. 大多数常见的过敏原在不同年龄组之间没有显著差异,支持一致使用标准补丁测试系列.
科学领域:
- 皮肤病学 皮肤病学
- 过敏学 过敏学
- 流行病学 流行病学
背景情况:
- 与年龄相关的因素可以影响贴片测试结果,但证据仍然不一致.
- 了解皮肤敏感化的特定年龄模式对于准确的诊断至关重要.
研究的目的:
- 为了评估特定年龄组的皮肤敏感性贴片试验结果.
- 评估与不同年龄人口群体的阳性贴片测试相关的相关性和临床特征.
主要方法:
- 一项前性多中心研究涉及13,368名患者,他们接受了西班牙基线系列的贴片测试.
- 患者被分为五个年龄组:儿童 (0-11岁),青少年 (12-18岁),年轻人 (19-30岁),中年人 (31-65岁) 和老年人 (≥66岁).
- 统计分析,包括多变量逻辑回归,根据年龄组比较敏感率,相关性和临床特征.
主要成果:
- 中年成年人表现出最高比例的阳性贴片测试结果和敏感性.
- 对于特定的过敏原,包括,二氧化和烯氧化,观察到与年龄相关的显著趋势.
- 与年轻成年人相比,多变量分析证实31-65岁和66岁以上的成年人具有较高的阳性补丁测试几率.
结论:
- 对皮肤敏感性的阳性贴片试验结果取决于年龄,在中年成年人中达到顶峰.
- 大多数测试过的过敏原没有显示出与年龄相关的显著变化.
- 这些发现支持在所有年龄组中继续使用标准基线系列进行补丁测试.
相关概念视频
02:20Longitudinal Research
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
01:18Patch Clamp
Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...